UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial

Annals of oncology, 2023-03, Vol.34 (3), p.251-261

2023

Volltextzugriff (PDF)

Consensus recommendations for management of head and neck cancer in Asian countries: A review of international guidelines

Oral oncology, 2013-09, Vol.49 (9), p.872-877

2013

Volltextzugriff (PDF)

P0151 Association of plasma CXCL12 and bone metastasis in advanced stage non-small-cell lung cancer

European journal of cancer (1990), 2014-05, Vol.50, p.e51-e52

2014

Volltextzugriff (PDF)

Effect of KRAS codon 12 or 13 mutations on survival with trifluridine/tipiracil in pretreated metastatic colorectal cancer: a meta-analysis

ESMO open, 2022-06, Vol.7 (3), p.100511-100511, Article 100511

2022

Volltextzugriff (PDF)

Paradoxical prognostic phenomenon of plasma T-cell-derived circulating DNA level in advanced non-small cell lung cancer

Clinical & translational oncology, 2020-07, Vol.22 (7), p.1117-1125

2020

Volltextzugriff (PDF)

Afatinib in chemotherapy pre-treated EGFR mutation-positive NSCLC

Annals of oncology, 2018-11, Vol.29, p.ix146-ix146

2018

Volltextzugriff (PDF)

P0179 Severe hypersensitivity reactions with original and generic taxanes: A prospective study at a medical oncology unit in Thailand

European journal of cancer (1990), 2014-05, Vol.50, p.e61-e61

2014

Volltextzugriff (PDF)

P0181 MiR-200C expression in Thai patients with cholangiocarcinoma

European journal of cancer (1990), 2014-05, Vol.50, p.e61-e62

2014

Volltextzugriff (PDF)

Phase I/II study of spartalizumab (PDR001), an anti-PD1 mAb, in patients with advanced melanoma or non-small cell lung cancer

Annals of oncology, 2018-10, Vol.29, p.viii413-viii413

2018

Volltextzugriff (PDF)

Primary efficacy and updated safety of ceritinib (450mg or 600mg) with food vs 750mg fasted in ALK+ metastatic NSCLC (ASCEND-8)

Annals of oncology, 2018-10, Vol.29, p.viii747-viii747

2018

Volltextzugriff (PDF)

AOS25 Prevalence of PTEN loss in triple negative breast cancer in the Thai population

European journal of cancer (1990), 2012-04, Vol.48, p.S12-S12

2012

Volltextzugriff (PDF)

A new human p53 homologue

Nature medicine, 1998-07, Vol.4 (7), p.747-748

1998

Volltextzugriff (PDF)

P0227 Utility of pre-treatment serum amphiregulin in colorectal carcinoma

European journal of cancer (1990), 2014-05, Vol.50, p.e73-e73

2014

Volltextzugriff (PDF)

AOS29 Predictive factors for severe neutropenia after the first chemotherapy cycle in patients with breast cancer

European journal of cancer (1990), 2012-04, Vol.48, p.S13-S13

2012

Volltextzugriff (PDF)

HERITAGE: a phase III safety and efficacy trial of the proposed trastuzumab biosimilar Myl-1401O versus herceptin

European journal of cancer (1990), 2017-02, Vol.72, p.S41-S41

2017

Volltextzugriff (PDF)

Monocyte count associates with subsequent symptomatic venous thromboembolism (VTE) in hospitalized patients with solid tumors

Thrombosis research, 2012-04, Vol.129, p.S172-S172

2012

Volltextzugriff (PDF)

EE63 Cost-Effectiveness and Budget Impact of Pembrolizumab Monotherapy As the First-Line Treatment for Metastatic Non-Small Cell Lung Cancer Patients with PD-L1 ≥ 50% in Thailand

Value in health, 2024-06, Vol.27 (6), p.S68-S69

2024

Volltextzugriff (PDF)

EP08.04-003 A Simple Clinical Prediction Score to Determine Response to First Line Chemotherapy Treatment in Advanced Non-Small Cell Lung Cancer Patients

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S495

2022

Volltextzugriff (PDF)

High frequency of mutation of epidermal growth factor receptor in lung adenocarcinoma in Thailand

Cancer letters, 2006-08, Vol.239 (2), p.292-297

2006

Volltextzugriff (PDF)

Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma

Clinical cancer research, 1998-03, Vol.4 (3), p.665-669

1998

Volltextzugriff (PDF)

172P T cell-derived circulating DNA and tumour inflammatory microenvironment in EGFR-mutant advanced non-small cell lung cancer: Correlation with the outcome of EGFR TKI treatment

Annals of oncology, 2023-10, Vol.34, p.S250-S250

2023

Volltextzugriff (PDF)

P42.02 Prognostic Indicators for Conventional Chemotherapy Response in Advanced Non-Small Cell Lung Cancer Patients in Resource-Limited Country

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S1080-S1081

2021

Volltextzugriff (PDF)

P45-3 Efficacy and safety of TS-ONE in advanced non-small cell lung cancer in Thailand: a multicenter retrospective study

Annals of oncology, 2024-10, Vol.35, p.S1379-S1380

2024

Volltextzugriff (PDF)

Randomized trial of two different doses of pyridoxine in the prevention of capecitabine-associated palmar-plantar erythrodysesthesia

Asia-Pacific journal of clinical oncology, 2010-09, Vol.6 (3), p.155-160

2010

Volltextzugriff (PDF)

1 – 25 von 135

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(131)
Mit Volltextzugriff
(135)

Publikationsform

Artikel
(135)

Sprache

Englisch
(135)

Erscheinungsjahr

n.n

Thema

Humans
(26)
Science & Technology
(26)
Life Sciences & Biomedicine
(25)
Oncology
(20)
Biological And Medical Sciences
(16)
Medical Sciences
(14)
Female
(11)
Hematology, Oncology And Palliative Medicine
(11)
Male
(11)
Tumors
(10)
Middle Aged
(9)
Aged
(8)
Adult
(7)
Otorhinolaryngology. Stomatology
(7)
Dna-Binding Proteins - Genetics
(6)
Nasopharyngeal Neoplasms - Genetics
(6)
Tumor Cells, Cultured
(6)
Aged, 80 And Over
(5)
Animals
(5)
Basic Helix-Loop-Helix Transcription Factors
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial

Osimertinib after definitive chemoradiotherapy in unresectable stage III epidermal growth factor receptor-mutated non-small-cell lung cancer: analyses of central nervous system efficacy and distant progression from the phase III LAURA study

Consensus recommendations for management of head and neck cancer in Asian countries: A review of international guidelines

P0151 Association of plasma CXCL12 and bone metastasis in advanced stage non-small-cell lung cancer

Effect of KRAS codon 12 or 13 mutations on survival with trifluridine/tipiracil in pretreated metastatic colorectal cancer: a meta-analysis

Paradoxical prognostic phenomenon of plasma T-cell-derived circulating DNA level in advanced non-small cell lung cancer

Afatinib in chemotherapy pre-treated EGFR mutation-positive NSCLC

P0179 Severe hypersensitivity reactions with original and generic taxanes: A prospective study at a medical oncology unit in Thailand

P0181 MiR-200C expression in Thai patients with cholangiocarcinoma

Phase I/II study of spartalizumab (PDR001), an anti-PD1 mAb, in patients with advanced melanoma or non-small cell lung cancer

Primary efficacy and updated safety of ceritinib (450mg or 600mg) with food vs 750mg fasted in ALK+ metastatic NSCLC (ASCEND-8)

AOS25 Prevalence of PTEN loss in triple negative breast cancer in the Thai population

A new human p53 homologue

P0227 Utility of pre-treatment serum amphiregulin in colorectal carcinoma

AOS29 Predictive factors for severe neutropenia after the first chemotherapy cycle in patients with breast cancer

HERITAGE: a phase III safety and efficacy trial of the proposed trastuzumab biosimilar Myl-1401O versus herceptin

Monocyte count associates with subsequent symptomatic venous thromboembolism (VTE) in hospitalized patients with solid tumors

EE63 Cost-Effectiveness and Budget Impact of Pembrolizumab Monotherapy As the First-Line Treatment for Metastatic Non-Small Cell Lung Cancer Patients with PD-L1 ≥ 50% in Thailand

EP08.04-003 A Simple Clinical Prediction Score to Determine Response to First Line Chemotherapy Treatment in Advanced Non-Small Cell Lung Cancer Patients

High frequency of mutation of epidermal growth factor receptor in lung adenocarcinoma in Thailand

Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma

172P T cell-derived circulating DNA and tumour inflammatory microenvironment in EGFR-mutant advanced non-small cell lung cancer: Correlation with the outcome of EGFR TKI treatment

P42.02 Prognostic Indicators for Conventional Chemotherapy Response in Advanced Non-Small Cell Lung Cancer Patients in Resource-Limited Country

P45-3 Efficacy and safety of TS-ONE in advanced non-small cell lung cancer in Thailand: a multicenter retrospective study

Randomized trial of two different doses of pyridoxine in the prevention of capecitabine-associated palmar-plantar erythrodysesthesia

Suchergebnisse filtern